 |
|
|
| |
Dolutegravir, Boceprevir, Telaprevir PK: The effect of Boceprevir and Telaprevir on Dolutegravir Pharmacokinetics, in Healthy Adult Subjects
|
| |
| |
Reported by Jules Levin
14th Clinical Pharmacology in HIV and HCV Workshop
April 22-24 2013 Amsterdam
ClinPharmWk: No Clinically Significant Interactions Between Boceprevir or Telaprevir and Dolutegravir - written by Mark Mascolini - (04/29/13)
14th Intrntnl Wrkshp Clinical Pharm HIV Therapy Clinical Pharmacology at the 14th Workshop on Clinical Pharmacology of HIV Therapy and HCV - Courtney V. Fletcher, Pharm.D. Dean and Professor College of Pharmacy University of Nebraska Medical Center - (05/20/13)
Mark Johnson, Julir Borland, Shuguang Chen, Paul Savina, Brian Wynne, Stephen Piscatelli, GlaxoSmithKline
|
| |
|
|
|
|
|
